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ABSTRACT AND KEYWORDS: 44 
Background: Current data on critical illness during pregnancy are insufficient for evidence-based 45 
decision-making. Core outcome sets are promoted to improve reporting of outcomes important to 46 
decision makers. We aim to develop a Core Outcome Set on Critically ill Obstetric patients (COSCO 47 
study).  48 
Methods: We will perform a systematic review of studies on critical illness in pregnancy and focus 49 
groups or interviews with women who were critically ill while being pregnant. These data will inform 50 
an international Delphi survey where stakeholders will rank proposed outcomes. Selected outcomes 51 
will be brought forward to a consensus meeting where core outcomes will be defined. We will then 52 
complete a second consensus process to define measures for each core outcome. 53 
Conclusion: The COSCO study aims to develop a set of core outcomes to be part of all studies on 54 
critically ill obstetric patients. Implementation of this core outcome set will help improve future 55 
research efforts. 56 
Trial registration: This study is registered on the COMET-initiative website (COS #916). This 57 
systematic review is registered on PROSPERO (CRD #42017071944). 58 
 59 
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 61 
BACKGROUND: 62 
Altered maternal physiology, fetal implications of medical intervention and psychosocial issues 63 
make the management of the critically ill pregnant woman extremely challenging.1 Critical illness 64 
during the antepartum period poses challenges such as determining the safety of interventions and 65 
the maternal and fetal risks associated with continuing the pregnancy.2 Although critical illness 66 
during the postpartum period does not directly affect the newborn, it could affect mother-child 67 
bonding, breastfeeding and family dynamics. 68 
 69 
Current data on critically ill pregnant women primarily comprises case reports and case series and 70 
are often insufficient for evidence-based decision-making. There are several reasons for the lack of 71 
good quality observational and interventional evidence. Firstly, critical illness requiring intensive 72 
care unit (ICU) admission during pregnancy is a rare event estimated to have an incidence of 0.7-73 
13.5 per 1000 deliveries and accounts for only 0.4% of all ICU admissions.3 Secondly, data and 74 
outcome reporting in existing studies is heterogeneous,3 making it difficult to compare outcomes 75 
between studies to inform evidence-based decision making. Thirdly, critically ill pregnant women are 76 
excluded or underrepresented in most completed or ongoing interventional trials involving ICU 77 
patients. Finally, study outcomes important to the mother, child and family members have not been 78 
elucidated. It is important that future research efforts tackle these issues by conducting multicentre 79 
studies with methodological rigour, focusing on issues considered important by pregnant women 80 
experiencing critical illness, and using standardized outcomes deemed essential by all 81 
stakeholders. 82 
 83 
Core Outcome Sets (COS) are increasingly being developed to identify outcomes important to 84 
decision makers, improve outcome reporting, as well as standardise definitions and measures.4 85 
COS are described and promoted by the Core Outcome Measures in Effectiveness Trials (COMET) 86 
Initiative, a group based in Liverpool and funded by the European Commission and the National 87 
Health Service National Institute for Health Research.5 This group defines COS as “the minimal 88 
outcomes that should be measured and reported in all clinical trials of a specific condition”.5 COS 89 
have been endorsed by major organizations such as the International Forum for Acute Care Trialists 90 
(InFACT)6 and the Core Outcomes in Women’s and Newborn Health (CROWN) initiative.7 InFACT 91 
is an international forum promoting COS development for critical care trials,6 a field where COS are 92 
still under developed compared to others.8 The CROWN initiative aims to harmonize outcome 93 
reporting in women’s health research which includes COS development for conditions affecting 94 
pregnant women.7  95 
 96 
With an overall aim of improving research in the field of critical illness in pregnancy, the COSCO 97 
study objective is to develop a COS for research on Critically ill Obstetric patients (during pregnancy 98 
and within six weeks postpartum). This paper describes our protocol for the development of this 99 
COS. Reporting of the protocol is important to ensure the eventual analysis and results are 100 
consistent with the investigators' original intent; to make researchers in the field aware that the COS 101 
process is underway to avoid duplication, to foster collaboration, and to provide a template for COS 102 
endeavors in related fields. 103 
 104 
METHODS: 105 
Overview: 106 
We will follow the recommendations of the COMET Initiative4 for development and the Core 107 
Outcome Set–STAndards for Reporting (COS-STAR) guidelines9 for reporting of this COS. The 108 
steps in the development of the COS are outlined in Figure 1. We will first identify outcomes on 109 
critical illness in pregnancy through the conduct of a systematic review, and focus groups and 110 
interviews with women who were critically ill while being pregnant and their partners. These 111 
outcomes will be used as the starting point to conduct a Delphi study involving multiple groups of 112 
stakeholders followed by consensus meetings to define core outcomes for inclusion in the COS. We 113 
will then perform a second similar consensus process to define how the included outcomes should 114 
be measured.10 We expect the study to be completed within an 18-month timeline. 115 
 116 
[Placeholder: Figure 1. Study flowchart.] 117 
 118 
Systematic review: 119 
We will perform a systematic review to identify outcomes reported in the literature (registered in 120 
PROSPERO CRD #42017071944).4, 11 We will complete an electronic search with relevant 121 
keywords in the following databases from inception to November 2017: MEDLINE, EMBASE, 122 
CINAHL, Latin American database LILAC, ISI Web of Science and the WHO Global Index Medicus. 123 
We will include studies on women admitted in an ICU or high-dependency unit during pregnancy or 124 
postpartum period (≤ 6 weeks). Two reviewers will screen studies and extract reported outcomes 125 
and their measurement properties such as definitions, time points and Outcome Measurement 126 
Instruments (OMI). 127 
 128 
Focus groups and interviews: 129 
We will conduct focus groups and individual interviews with women who were critically ill while being 130 
pregnant and their partners to identify patient-important outcomes which can be different from those 131 
published in the literature.12-14 At least two groups of women will be interviewed including one group 132 
in a low or low-middle income country. We will classify countries using the 2017-2018 World Bank 133 
Country Classification.15 Each site conducting focus groups and interviews will obtain local research 134 
ethics board (REB) approval to recruit women and their partners, who will be identified by reviewing 135 
the previous years’ ICU admissions at participating sites and who will be contacted by postal letters. 136 
 137 
Focus groups and interviews will be led by local researchers in countries representing various 138 
economic levels. These will be conducted and recorded with the help of experts in qualitative research 139 
methodology from each site according to a predefined script translated into the local language 140 
(Appendix 1). The recorded interviews will be translated into English and analysed with the help of 141 
qualitative researchers. Definitions of outcomes and COS using COMET plain language summaries 142 
will be provided.5 Patients and partners will be asked to discuss outcomes they consider relevant and 143 
their rationale. Discussions will last for 90 minutes or until no further outcomes are suggested. 144 
Discussions will be recorded, transcribed and translated into English if necessary.  145 
 146 
We will analyse focus groups and interviews transcriptions as previously described.16, 17 Outcomes 147 
described by women and partners will compared to the systematic review results to make sure they 148 
represent unique outcomes excluding outcomes with similar meaning or wording. Lay language 149 
terms used by participants will be recorded.12 A final list of outcomes will be created using outcomes 150 
obtained through the systematic review and the focus group. These outcomes will be coded into 151 
domains using the new outcomes taxonomy and will inform the next step.18 152 
 153 
Delphi study: 154 
Achievement of consensus between stakeholders is essential to COS development.19 We aim to 155 
include participants from multiple key stakeholder groups as a wide range of expertise is considered 156 
valuable.19 We will recruit participants from the five subgroups specified in Table 1. 157 
 158 
[Placeholder: Table 1. Stakeholders subgroups included in the Delphi panel.] 159 
 160 
To achieve consensus, we will use the Delphi technique.22 We will lead at least two survey rounds 161 
informed by group feedback where stakeholders will rank outcomes suggested until the defined 162 
consensus is reached. As mentioned earlier, the first round will be informed by outcomes identified 163 
by our systematic review and focus groups. We will attempt to minimise response bias and influence 164 
of power differentials to facilitate patients’ involvement by assuring anonymity, limiting group 165 
interaction and providing controlled feedback to participants.23-26 166 
 167 
There is no universally accepted size for a Delphi study panel,4, 10 but recently published COS in the 168 
fields of critical care and obstetrics used panels between 75 and 150 participants.27-29 We will 169 
attempt to recruit between 15-30 representatives for subgroups 1 to 3 and 5-10 representatives for 170 
subgroups 4 to 5 for a total of 75 or more stakeholders. 171 
 172 
Outcomes of critical illness during pregnancy differ between countries by income level.3 We will 173 
therefore attempt to include English speaking stakeholders representing low and lower-middle 174 
income countries.  175 
 176 
Stakeholder recruitment: 177 
We will use a multi-modal strategy to recruit Delphi participants. We will identify organisations (eg. 178 
professional societies, trial groups, charities) relevant to stakeholder groups using personal 179 
networks and a web-based search. Primary contacts within each organisation (e.g. Director, 180 
Administrator) will be emailed and asked to propose stakeholders or to disseminate our recruitment 181 
letter to their members.  182 
 183 
Other methods for contacting stakeholders include: advertisement at medical conferences and 184 
through professional societies for clinicians; personal invitation to the corresponding and senior 185 
authors of relevant studies identified through our systematic review. We will ask clinicians within our 186 
personal networks to identify former patients or caregivers that might be interested in an opportunity 187 
to participate in the study and to invite them to contact us. Finally, we will use social media (eg. Twitter, 188 
Facebook), including sites of support groups and patient blogs to circulate study recruitment 189 
information. 190 
 191 
We will use the COMET plain language summaries to describe the COS concept and the Delphi 192 
process.5, 25 We will provide definitions in lay language terms for pregnancy, postpartum and critical 193 
illness, and describe each participant’s expected involvement and time investment. We will inform 194 
stakeholders that participation in the study will be indicative of consent to use anonymized data for 195 
future publications. We will collect data on participants’ home country, age, and sex. In addition, 196 
clinicians and researchers will be asked to indicate their profession, speciality, current position, and 197 
years of experience. 198 
 199 
Procedure for the Delphi study: 200 
We will manage the Delphi process using the Delphi Manager online software (COMET initiative, 201 
United Kingdom).5 The Delphi will comprise two rounds with a third round if additional outcomes 202 
suggested by participants in round one are retained after the second round. Each round will take place 203 
over six weeks and will start 2-4 weeks after the previous round to enable data synthesis. We will 204 
attempt to minimize attrition by sending biweekly reminders and making each round as concise as 205 
possible. Participants who have not participated in a round despite reminders will be excluded from 206 
future rounds. 207 
 208 
First round: 209 
We will format all outcomes derived from our systematic review and focus groups in commonly used 210 
terms with explanations available in non-medical language. Participants of various stakeholders 211 
groups will be involved to develop outcome labels and explanations. We will group outcomes into 212 
domains for which the order will be randomized for each participant. We will pilot test the list with 213 
participants prior to providing the list to stakeholders.4  214 
 215 
In round 1, we will ask participants to rate the importance of each proposed outcome using the nine-216 
point Grading of Recommendations Assessment, Development and Evaluations (GRADE) scale.30 217 
Using this scale, scores 0-3 are considered of low importance, 4-6 important but not critical and 7-9 218 
of critical importance. Participants will be asked to suggest any additional outcomes that they judge 219 
important for consideration for the COS.  220 
 221 
We will calculate the percentage of each score (1 to 9) based on the total number of responses and 222 
the median rating and interquartile range for every proposed outcome. We will calculate the median 223 
rating and interquartile range for each outcome for the following pooled participant category: 1) 224 
clinicians, 2) patients, partners, and patient support group representatives, 3) researchers and journal 225 
editors. The feedback will be provided to stakeholders using a graphical summary of scores by pooled 226 
stakeholder category. Any new outcomes suggested by participants will be reviewed by the research 227 
team to ensure they represent new outcomes and will be worded appropriately for subsequent rounds 228 
including a non-medical language explanation. 229 
 230 
Second and third rounds: 231 
On subsequent rounds, we will send the list of outcomes to participants to rescore in terms of 232 
importance. To reduce participant burden, we will retain outcomes which within each pooled subgroup 233 
at least 50% of participants scored as critically important and less than 15% scored not important 234 
during previous round. For each proposed outcome, we will provide stakeholders with their previous 235 
rating and a graphical summary of scores by stakeholder subgroups. Participants will be asked again 236 
to rate each outcome using the same 9-point scale. 237 
 238 
Consensus definition: 239 
There is currently no universally accepted definition of consensus as to which scores on the 9-point 240 
scale indicate items that should be brought to a COS consensus meeting, but recent COS have used 241 
similar definitions.19, 31 We will therefore define consensus as an outcome which at least 70 % of the 242 
panel members have rated as critically important and less then 15 % have rated as not important.19 243 
Outcomes fulfilling those criteria at the end of the final round will be moved forward to the consensus 244 
meeting. 245 
 246 
Consensus meeting: 247 
We will conduct a virtual consensus meeting to discuss the outcomes brought forward from the Delphi 248 
and to vote on outcomes for inclusion in the COS. We aim to involve 5-10 representatives from each 249 
of the stakeholder groups. If more stakeholders are interested than the number of desired attendees 250 
we will randomly select attendees within each group. If required we may complete a standalone 251 
briefing prior to the consensus meeting involving only patients, partners and representatives from 252 
patient support groups to allow discussions in lay language and facilitate their understanding. 253 
Although logistically more difficult than conducting face-to-face meetings, we have opted for virtual 254 
meetings in order to ensure involvement of participants (patients and caregivers) from around the 255 
world. Discussions will be moderated by an experienced facilitator and will follow a modified nominal 256 
group technique.32 We will involve information technology teams to ensure the smooth conduct of 257 
these meetings. After presentation of the outcomes brought to the consensus meetings, we will ask 258 
participants which outcomes they consider essential to the COS and their rationale. We will then lead 259 
group discussions with the aim of ranking the top four to six core outcomes to be part of the COS.  260 
 261 
Outcome measurement: 262 
After having determined which outcomes should be part of the COS we will define how to measure 263 
them. As suggested by the COnsensus-based Standards for the selection of health Measurement 264 
INstruments (COSMIN),10, 33 we will collect data in our systematic review on measurement 265 
properties of reported outcomes. If outcomes not identified in our systematic review are selected as 266 
core outcomes we will perform an additional electronic search in the MEDLINE and EMBASE 267 
databases to identify their measurement properties. We will also search the COSMIN33 and 268 
COMET5 databases for data on OMI quality such as reliability, validity and feasibility. We will 269 
evaluate the measurement and psychometric properties of OMIs using the COSMIN checklist.33, 34 270 
 271 
We will invite stakeholders that completed the COS development to join a second consensus 272 
process. We will provide them data about the measurement and psychometric characteristics of 273 
OMIs. Using the same consensus methods as the COS development we will run a Delphi survey 274 
and consensus meetings to provide recommended measures for each core outcome. 275 
 276 
Dissemination and implementation: 277 
We will work with researchers and journal editors to disseminate and implement the COS. We aim 278 
to present the COS at international conferences in the fields of critical care, obstetrics and 279 
obstetrical medicine. The COS will be submitted for publication in peer-reviewed journals in critical 280 
care and obstetrics. We will also work the COMET5, InFACT6 and CROWN initiatives7 to publish the 281 
COS in their databases.  282 
 283 
Ethical considerations: 284 
We have obtained ethical approval from the Mount Sinai Hospital REB (Application 17-0238-E). 285 
Participation in the electronic Delphi survey will be considered indicative of consent. We will obtain 286 
written consent from focus groups, interviews and consensus meetings participants. Recruitment 287 
letters and consent forms will stress the voluntary nature of participation and anonymity. 288 
 289 
 290 
LIST OF ABBREVIATIONS: 291 
COMET: Core Outcome Measures in Effectiveness Trials 292 
COS: Core Outcome Set 293 
COSMIN: COnsensus-based Standards for the selection of health Measurement INstruments 294 
CROWN: Core Outcomes in Women’s and Newborn Health 295 
GRADE: Grading of Recommendations Assessment, Development and Evaluations  296 
ICU: Intensive Care Unit 297 
InFACT: International Forum for Acute Care Trialists 298 
OMI: Outcome Measurement Instrument 299 
REB: Research Ethics Board 300 
 301 
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Figure 1. Study flowchart.  391 
 392 
 393 
 394 
 395 
 396 
 397 
 398 
 399 
Table 1. Stakeholders subgroups included in the Delphi panel. 400 
Subgroup Inclusion criteria 
1. Clinicians Clinicians with practical knowledge and at least five years’ experience in the 
fields of: 
• Obstetrical critical care 
• High-risk obstetrics / maternal-fetal medicine 
• Obstetrical medicine 
• Obstetrical anaesthesia 
• Obstetrical and critical care nursing 
• Midwifery 
• Neonatology / pediatrics 
2. Researchers Primary or senior authors of peer-reviewed papers in the last 10 years in the field 
of obstetrical critical care identified through our systematic review 
3. Women and 
partners 
Women who were critically ill while being pregnant and their partners 
 
4. Patient support 
groups 
Representatives of patient support groups for pregnant women or critically ill 
patients (eg. Preclampsia Foundation 20, ICUsteps 21) 
5. Journal editors Editors from high impact peer-reviewed journals in the fields of obstetrics, 
obstetrical medicine and critical care 
 401 
 402 
